DE602005013935D1 - Anionische hydrogelmatrizes mit ph-abhängiger modifizerter wirkstofffreisetzung als arzneimittelträger - Google Patents

Anionische hydrogelmatrizes mit ph-abhängiger modifizerter wirkstofffreisetzung als arzneimittelträger

Info

Publication number
DE602005013935D1
DE602005013935D1 DE602005013935T DE602005013935T DE602005013935D1 DE 602005013935 D1 DE602005013935 D1 DE 602005013935D1 DE 602005013935 T DE602005013935 T DE 602005013935T DE 602005013935 T DE602005013935 T DE 602005013935T DE 602005013935 D1 DE602005013935 D1 DE 602005013935D1
Authority
DE
Germany
Prior art keywords
dependent
medicamental
carrier
modified active
hydrogel matrices
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005013935T
Other languages
English (en)
Inventor
Gaetano Giammona
Delia Mandracchia
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Industrie Farmaceutiche Riunite SpA filed Critical Sigma Tau Industrie Farmaceutiche Riunite SpA
Publication of DE602005013935D1 publication Critical patent/DE602005013935D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
DE602005013935T 2004-04-01 2005-02-16 Anionische hydrogelmatrizes mit ph-abhängiger modifizerter wirkstofffreisetzung als arzneimittelträger Active DE602005013935D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000168A ITRM20040168A1 (it) 2004-04-01 2004-04-01 Composizione a rilascio modificato ph dipendente.
PCT/IT2005/000081 WO2005094792A1 (en) 2004-04-01 2005-02-16 Anionic hydrogel matrices with ph dependent modified release as drug carriers

Publications (1)

Publication Number Publication Date
DE602005013935D1 true DE602005013935D1 (de) 2009-05-28

Family

ID=34961555

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005013935T Active DE602005013935D1 (de) 2004-04-01 2005-02-16 Anionische hydrogelmatrizes mit ph-abhängiger modifizerter wirkstofffreisetzung als arzneimittelträger

Country Status (20)

Country Link
US (1) US20070166383A1 (de)
EP (1) EP1729732B1 (de)
JP (1) JP2007530666A (de)
KR (1) KR20060133578A (de)
CN (1) CN1913875B (de)
AT (1) ATE428405T1 (de)
AU (1) AU2005228716B2 (de)
BR (1) BRPI0509475A (de)
CA (1) CA2551797A1 (de)
CY (1) CY1109209T1 (de)
DE (1) DE602005013935D1 (de)
DK (1) DK1729732T3 (de)
ES (1) ES2325626T3 (de)
HR (1) HRP20090329T1 (de)
IT (1) ITRM20040168A1 (de)
PL (1) PL1729732T3 (de)
PT (1) PT1729732E (de)
RS (1) RS51178B (de)
SI (1) SI1729732T1 (de)
WO (1) WO2005094792A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4746883B2 (ja) * 2005-01-28 2011-08-10 リンテック株式会社 ハイドロゲル基剤、パップ剤基剤、パップ剤及び水性ゲルシート
CN102325596B (zh) 2008-12-31 2015-04-29 3M创新有限公司 使用微粒进行的活生物负载检测
WO2010078399A2 (en) 2008-12-31 2010-07-08 3M Innovative Properties Company Sampling devices and methods for concentrating microorganisms
WO2011082258A2 (en) 2009-12-30 2011-07-07 Regents Of The University Of Minnesota Bone cement and method
EP2519355B1 (de) 2009-12-30 2017-01-25 3M Innovative Properties Company Nachweis von lebender bioladung mit mikropartikeln
WO2011090349A2 (ko) * 2010-01-21 2011-07-28 광주과학기술원 피부투과도, 세포유입 및 종양전달성이 증가된 나노운반체
KR101228106B1 (ko) * 2010-01-21 2013-02-01 광주과학기술원 피부투과도, 세포유입 및 종양전달성이 증가된 나노운반체
CN103330702B (zh) * 2013-07-02 2016-03-02 江苏长泰药业有限公司 含有拟交感神经胺盐和诱导凝胶体系的医药组合物
CN108452291A (zh) * 2018-07-04 2018-08-28 西南大学 用天然丝胶蛋白治疗溃疡性结肠炎的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4071508A (en) * 1975-02-11 1978-01-31 Plastomedical Sciences, Inc. Anionic hydrogels based on hydroxyalkyl acrylates and methacrylates
IT1284661B1 (it) * 1996-06-06 1998-05-21 Sigma Tau Ind Farmaceuti Uso di alcanoil l-carnitine nel trattamento terapeutico di malattie infiammatorie croniche intestinali.
DE19653631A1 (de) * 1996-12-20 1998-06-25 Basf Coatings Ag Verfahren zum Herstellen von durch Strahlung vernetzbaren polymeren Acryl- oder Methacrylsäureestern
EP0986408B1 (de) * 1997-06-03 2005-05-11 Innogenetics N.V. Neue arzneimittel auf der basis von polymeren aus mit methacrylamid modifizierter gelatine
CN1230152C (zh) * 1999-02-03 2005-12-07 鲍德杰克特研究有限公司 水凝胶颗粒制剂
US6547182B2 (en) * 2001-07-19 2003-04-15 Aerojet-General Corporation Solid rocket motor bolted thrust takeout structure
US7204997B2 (en) * 2002-01-29 2007-04-17 Supratek Pharma Inc. Responsive microgel and methods related thereto

Also Published As

Publication number Publication date
CY1109209T1 (el) 2014-07-02
BRPI0509475A (pt) 2007-09-11
EP1729732A1 (de) 2006-12-13
PT1729732E (pt) 2009-07-02
WO2005094792A1 (en) 2005-10-13
US20070166383A1 (en) 2007-07-19
DK1729732T3 (da) 2009-08-10
ATE428405T1 (de) 2009-05-15
SI1729732T1 (sl) 2009-08-31
CA2551797A1 (en) 2005-10-13
RS51178B (sr) 2010-10-31
KR20060133578A (ko) 2006-12-26
CN1913875A (zh) 2007-02-14
AU2005228716B2 (en) 2010-07-15
AU2005228716A1 (en) 2005-10-13
ES2325626T3 (es) 2009-09-10
ITRM20040168A1 (it) 2004-07-01
HRP20090329T1 (en) 2009-09-30
EP1729732B1 (de) 2009-04-15
CN1913875B (zh) 2011-08-31
JP2007530666A (ja) 2007-11-01
PL1729732T3 (pl) 2009-09-30

Similar Documents

Publication Publication Date Title
DE602005013935D1 (de) Anionische hydrogelmatrizes mit ph-abhängiger modifizerter wirkstofffreisetzung als arzneimittelträger
UA100851C2 (ru) Средство для борьбы с паразитами на животных
MXPA05007328A (es) Composiciones que contienen agentes antiacne y el uso de las mismas.
EA201000089A1 (ru) Применение гомо- и сополимеров для стабилизации составов активных ингредиентов
TW200800967A (en) Benzimidazole thiophene compounds
TR201911270T4 (tr) Polimerik mirsen bileşimleri.
WO2005118008A3 (en) Compositions and articles containing a crosslinked polymer matrix and an immobilized active liquid, as well as methods of making and using the same
BRPI0518869A2 (pt) agentes citotàxicos compreendendo taxanos
HRP20070374T3 (en) Formulations comprising ecteinascidin and a disaccharide
MXPA06014470A (es) Formulaciones oftalmicas que incluyen antagonistas de alfa 1 selectivas.
ATE459620T1 (de) Benzimidazolthiophenverbindungen als plk- modulatoren
ECSP066909A (es) Ascorbato de bazedoxifeno como modulador del receptor de estrogeno selectivo
EA200800713A1 (ru) Аморфные твёрдые дисперсии
EA200701172A1 (ru) 2-алкокси-3,4,5-тригидроксиалкиламиды, их получение, композиции, их содержащие, и применение
TW200613003A (en) Active compound-containing solid moulded bodies for external use against parasites on animals
GT200600121A (es) Novedosos derivados de triazolopirimidina
GT200300046A (es) Indolil-urea derivados de tienopiridinas utiles como agentes antiangiogenicos y procedimientos para su uso
BRPI0414008B8 (pt) compostos que se ligam a um receptor de trombopoietina, composições e métodos in vitro para ativação de um receptor de trombopoietina em uma célula
ATE517171T1 (de) Verbesserungen bei organischen zusammensetzungen
MX2009005817A (es) Agentes para combatir parasitos en animales.
UA87903C2 (en) Herbicidal composition
UY28812A1 (es) Agente parasiticida
CY1109541T1 (el) Φαρμακευτικη συνταγοποιηση για την θεραπεια οστεοαρθριτιδας η οποια περιεχει κλοδρονικο οξυ και υαλουρονικο οξυ
EA200701892A1 (ru) Композиции, содержащие связанную воду и компоненты, помещённые в водочувствительную основу
PL376130A1 (en) Controlled releases system containing temozolomide

Legal Events

Date Code Title Description
8364 No opposition during term of opposition